Published in J Virol on April 01, 1985
Nucleotide sequence of the G protein gene of human respiratory syncytial virus reveals an unusual type of viral membrane protein. Proc Natl Acad Sci U S A (1985) 3.93
Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol (1993) 2.94
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
The transmembrane domain in viral fusion: essential role for a conserved glycine residue in vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1998) 1.99
Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol (2004) 1.78
Functions of signal and signal-anchor sequences are determined by the balance between the hydrophobic segment and the N-terminal charge. Proc Natl Acad Sci U S A (1992) 1.72
Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Mol Cell Biol (1990) 1.66
Neutralization map of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus: domains recognized by monoclonal antibodies that prevent receptor recognition. J Virol (1991) 1.65
The large external domain is sufficient for the correct sorting of secreted or chimeric influenza virus hemagglutinins in polarized monkey kidney cells. J Cell Biol (1987) 1.59
Identification and predicted sequence of a previously unrecognized small hydrophobic protein, SH, of the paramyxovirus simian virus 5. J Virol (1985) 1.53
Integration of a small integral membrane protein, M2, of influenza virus into the endoplasmic reticulum: analysis of the internal signal-anchor domain of a protein with an ectoplasmic NH2 terminus. J Cell Biol (1988) 1.44
Human parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein: nucleotide sequence of mRNA and limited amino acid sequence of the purified protein. J Virol (1986) 1.42
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Role of a single amino acid at the amino terminus of the simian virus 5 F2 subunit in syncytium formation. J Virol (1997) 1.26
Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. J Virol (1987) 1.26
Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26
Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J Virol (2001) 1.17
Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J Mol Biol (2008) 1.16
Analysis in vivo of GRP78-BiP/substrate interactions and their role in induction of the GRP78-BiP gene. Mol Biol Cell (1992) 1.10
Structure and function of bicistronic RNA encoding the phosphoprotein and matrix protein of measles virus. J Virol (1987) 1.09
The paramyxovirus simian virus 5 hemagglutinin-neuraminidase glycoprotein, but not the fusion glycoprotein, is internalized via coated pits and enters the endocytic pathway. Mol Biol Cell (1996) 1.08
Flux of the paramyxovirus hemagglutinin-neuraminidase glycoprotein through the endoplasmic reticulum activates transcription of the GRP78-BiP gene. J Virol (1991) 1.05
Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis. J Virol (2001) 1.03
Cell surface expression of glycosylated, nonglycosylated, and truncated forms of a cytoplasmic protein pyruvate kinase. J Cell Biol (1988) 1.02
Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins. Nucleic Acids Res (1987) 1.01
Intracellular maturation of mumps virus hemagglutinin-neuraminidase glycoprotein: conformational changes detected with monoclonal antibodies. J Virol (1986) 0.99
Defective assembly and intracellular transport of mutant paramyxovirus hemagglutinin-neuraminidase proteins containing altered cytoplasmic domains. J Virol (1990) 0.98
High-level eucaryotic in vivo expression of biologically active measles virus hemagglutinin by using an adenovirus type 5 helper-free vector system. J Virol (1988) 0.97
Biology of parainfluenza viruses. Clin Microbiol Rev (1994) 0.95
A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5. J Virol (2001) 0.94
Sequence of 2,617 nucleotides from the 3' end of Newcastle disease virus genome RNA and the predicted amino acid sequence of viral NP protein. Nucleic Acids Res (1986) 0.89
Translation and membrane insertion of the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Mol Cell Biol (1987) 0.84
Analysis of parainfluenza virus-5 hemagglutinin-neuraminidase protein mutants that are blocked in internalization and degradation. Virology (2010) 0.83
Mutagenesis of Paramyxovirus Hemagglutinin-Neuraminidase Membrane-Proximal Stalk Region Influences Stability, Receptor Binding, and Neuraminidase Activity. J Virol (2016) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res (1984) 181.98
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature (1981) 24.17
Intracellular protein topogenesis. Proc Natl Acad Sci U S A (1980) 13.40
Secretion and membrane localization of proteins in Escherichia coli. CRC Crit Rev Biochem (1980) 5.57
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature (1983) 5.56
Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature (1980) 5.25
Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature (1983) 5.11
The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis (1980) 4.61
Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology (1972) 4.05
Structure of the neuraminidase gene in human influenza virus A/PR/8/34. Nature (1981) 3.56
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
A DNA sequence analysis package for the IBM personal computer. Nucleic Acids Res (1984) 1.96
Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology (1984) 1.88
Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87
Sequence of the influenza A/Udorn/72 (H3N2) virus neuraminidase gene as determined from cloned full-length DNA. Virology (1982) 1.56
The mode of association of the enzyme complex sucrase.isomaltase with the intestinal brush border membrane. J Biol Chem (1979) 1.50
On the hydrophobic part of aminopeptidase and maltases which bind the enzyme to the intestinal brush border membrane. Biochim Biophys Acta (1976) 1.48
The hemagglutinating and neuraminidase protein of a paramyxovirus: interaction with neuraminic acid in affinity chromatography. Virology (1974) 1.36
The carboxyterminus of the hemagglutinin-neuraminidase of Newcastle disease virus is exposed at the surface of the viral envelope. Virus Res (1984) 1.31
The carbohydrate structure of the glycoproteins of the paramyxovirus SV5 grown in bovine kidney cells. J Biol Chem (1979) 1.22
The HN glycoprotein of Sendai virus: analysis of site(s) involved in hemagglutinating and neuraminidase activities. Virology (1981) 1.21
Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide. J Gen Virol (1980) 0.94
AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell (1996) 9.74
Influenza virus M2 protein has ion channel activity. Cell (1992) 8.52
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40
Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell (1985) 6.44
Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins. Proc Natl Acad Sci U S A (1981) 5.57
Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions. J Virol (1988) 5.31
Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J Virol (1993) 4.76
Folding and assembly of viral membrane proteins. Virology (1993) 4.63
The gene structure and replication of influenza virus. Annu Rev Biochem (1983) 4.30
Evidence for a ninth influenza viral polypeptide. Virology (1978) 4.21
Sequence of interrupted and uninterrupted mRNAs and cloned DNA coding for the two overlapping nonstructural proteins of influenza virus. Cell (1980) 4.18
Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell (1999) 4.17
A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci U S A (1997) 4.03
Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell (1988) 3.98
Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell (1991) 3.98
Influenza virus M2 integral membrane protein is a homotetramer stabilized by formation of disulfide bonds. Virology (1991) 3.83
Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. EMBO J (2001) 3.76
Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology (1997) 3.58
Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. J Virol (2000) 3.39
Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1995) 3.38
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J (1997) 3.23
Polypeptides specified by the influenza virus genome I. Evidence for eight distinct gene products specified by fowl plague virus. Virology (1976) 3.20
Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol (1993) 3.17
Synthesis of influenza virus proteins in infected cells: translation of viral polypeptides, including three P polypeptides, from RNA produced by primary transcription. Virology (1976) 3.13
A previously unrecognized influenza B virus glycoprotein from a bicistronic mRNA that also encodes the viral neuraminidase. Proc Natl Acad Sci U S A (1983) 3.08
A role for the adenovirus inducible E2F transcription factor in a proliferation dependent signal transduction pathway. EMBO J (1990) 3.07
ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol Cell Biol (1998) 3.06
Activation of the M2 ion channel of influenza virus: a role for the transmembrane domain histidine residue. Biophys J (1995) 3.06
Influenza A virus M2 ion channel protein: a structure-function analysis. J Virol (1994) 3.02
The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology (2001) 2.83
Fusion protein of the paramyxovirus simian virus 5: nucleotide sequence of mRNA predicts a highly hydrophobic glycoprotein. Proc Natl Acad Sci U S A (1984) 2.82
The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation. Mol Cell Biol (1995) 2.70
A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology (1998) 2.61
ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Mol Cell Biol (2001) 2.60
Mapping of the two overlapping genes for polypeptides NS1 and NS2 on RNA segment 8 of influenza virus genome. Proc Natl Acad Sci U S A (1980) 2.60
Segment 8 of the influenza virus genome is unique in coding for two polypeptides. Proc Natl Acad Sci U S A (1979) 2.58
Characterization of the influenza virus M2 integral membrane protein and expression at the infected-cell surface from cloned cDNA. J Virol (1985) 2.58
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology (1977) 2.48
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
The M1 and M2 proteins of influenza A virus are important determinants in filamentous particle formation. Virology (1998) 2.43
CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol (1996) 2.42
The paramyxovirus SV5 V protein binds two atoms of zinc and is a structural component of virions. Virology (1995) 2.40
Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology (2000) 2.39
Measles and subacute sclerosing panencephalitis virus proteins: lack of antibodies to the M protein in patients with subacute sclerosing panencephalitis. Proc Natl Acad Sci U S A (1979) 2.33
Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport. J Virol (1994) 2.31
Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem (1997) 2.27
Identification of a second protein (M2) encoded by RNA segment 7 of influenza virus. Virology (1981) 2.26
Polypeptide synthesis in simian virus 5-infected cells. J Virol (1977) 2.20
The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc Natl Acad Sci U S A (1997) 2.19
The remarkable coding strategy of borna disease virus: a new member of the nonsegmented negative strand RNA viruses. Virology (1995) 2.17
Determination by peptide mapping of the unique polypeptides in Sendai virions and infected cells. Virology (1978) 2.17
Mechanism for proton conduction of the M(2) ion channel of influenza A virus. J Biol Chem (2000) 2.13
The V protein of the paramyxovirus SV5 interacts with damage-specific DNA binding protein. Virology (1998) 2.13
Topology of eukaryotic type II membrane proteins: importance of N-terminal positively charged residues flanking the hydrophobic domain. Cell (1991) 2.11
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
The influenza virus hemagglutinin cytoplasmic tail is not essential for virus assembly or infectivity. EMBO J (1994) 2.01
Direct measurement of the influenza A virus M2 protein ion channel activity in mammalian cells. Virology (1994) 1.99
The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol (1998) 1.98
Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol (2001) 1.95
Eukaryotic coupled translation of tandem cistrons: identification of the influenza B virus BM2 polypeptide. EMBO J (1990) 1.95
Ion selectivity and activation of the M2 ion channel of influenza virus. Biophys J (1996) 1.94
Conservation of the influenza virus membrane protein (M1) amino acid sequence and an open reading frame of RNA segment 7 encoding a second protein (M2) in H1N1 and H3N2 strains. Virology (1981) 1.94
Reconstitution of the influenza virus M2 ion channel in lipid bilayers. J Membr Biol (1994) 1.91
Permeation and activation of the M2 ion channel of influenza A virus. J Biol Chem (2000) 1.90
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Analysis and gene assignment of mRNAs of a paramyxovirus, simian virus 5. Virology (1984) 1.88
Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology (1996) 1.87
Spliced and unspliced messenger RNAs synthesized from cloned influenza virus M DNA in an SV40 vector: expression of the influenza virus membrane protein (M1). Virology (1982) 1.87
Effect of cytoplasmic tail truncations on the activity of the M(2) ion channel of influenza A virus. J Virol (1999) 1.87
The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J Virol (2000) 1.85
Complete nucleotide sequence of the neuraminidase gene of influenza B virus. Proc Natl Acad Sci U S A (1982) 1.85
A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem (2000) 1.84
The ion channel activity of the influenza virus M2 protein affects transport through the Golgi apparatus. J Cell Biol (1996) 1.83
Functional domains of the t(8;21) fusion protein, AML-1/ETO. Oncogene (1995) 1.83
Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol (1990) 1.82
Influenza B virus genome: sequences and structural organization of RNA segment 8 and the mRNAs coding for the NS1 and NS2 proteins. J Virol (1982) 1.81
Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep (2000) 1.79
The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene (1995) 1.78
In vitro synthesis of structural and nonstructural proteins of Sendai and SV5 viruses. Virology (1980) 1.78
Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr Top Microbiol Immunol (2004) 1.77
Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion. J Virol (1992) 1.76
Alterations to influenza virus hemagglutinin cytoplasmic tail modulate virus infectivity. J Virol (1992) 1.74
Growth restriction of influenza A virus by M2 protein antibody is genetically linked to the M1 protein. Proc Natl Acad Sci U S A (1989) 1.69
Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1. Mol Cell Biol (1998) 1.69
The polypeptides of canine distemper virus: synthesis in infected cells and relatedness to the polypeptides of other morbilliviruses. Virology (1980) 1.69
RNA editing by G-nucleotide insertion in mumps virus P-gene mRNA transcripts. J Virol (1990) 1.68
Analysis of the relationship between cleavability of a paramyxovirus fusion protein and length of the connecting peptide. J Virol (1989) 1.68